Oliver Schubert
Adelaide Medical School
Faculty of Health and Medical Sciences
A/Professor K. Oliver Schubert
My research focuses on the molecular underpinnings of psychiatric disorders such as schizophrenia, bipolar disorder, and major depression. I am particularly interested in transcriptomic and proteomic signatures of clinical endophenotypes (subtypes), treatment response and treatment resistance. This research is facilitated through a number of growing clinical cohorts (e.g. mood disorders, psychotic disorders, perinatal mental health) developed at the Discipline of Psychiatry, as well as through post-mortem brain research and animal models. I have a clinical special interest in Youth Mental Health and in the treatment of Early Psychosis.
Education:
2013 Royal Australian and New Zealand College of Psychiatry Australia FRANZCP
2011 The College of Psychiatry of Ireland Ireland Certificate of Satisfactory Completion of Specialist Training (CSCST)
2009 The Institute for Commercial Management United Kingdom Postgraduate Diploma in Health Service Management
2008 Royal College of Psychiatrists United Kingdom MRCPsych
2008 - 2014 Royal College of Surgeons in Ireland Ireland PhD
2000 - 2005 Institute for Anatomy and Cell Biology, University of Freiburg Germany Doctor of Medicine (MD)
1998 - 2004 University of Freiburg Germany State Exam Medicine
- My Research
- Career
- Publications
- Grants and Funding
- Teaching
- Supervision
- Professional Activities
- Contact
Research
My research focuses on the molecular underpinnings of psychiatric disorders such as schizophrenia, bipolar disorder, and major depression. I am particularly interested in transcriptomic and proteomic signatures of clinical endophenotypes (subtypes), treatment response and treatment resistance. This research is facilitated through a number of growing clinical cohorts (e.g. mood disorders, psychotic disorders, perinatal mental health) developed at the Discipline of Psychiatry, as well as through post-mortem brain research and animal models. I have a clinical special interest in Youth Mental Health and in the treatment of Early Psychosis.
Current research projects:
PROTECTIVE TRIAL (collaboration with Department of Anaesthesia - A/Professor Bernd Froessler): As part of this clinical trial (300 participants), we are investigating the impact of iron deficiency in on women’s mental health outcomes such as anxiety, depression, and cognitive function. We are also finding out whether treatment of iron deficiency by iron infusion positively influences mental health outcomes during the first year after giving birth. |
ASTHMA IN PREGNANCY STUDY (collaboration with the Robinson Institute – Professor Vicki Clifton/ Dr Luke Grzeskowiak) Over 300 participants were enrolled in this project investigating the impact of asthma on pregnancy outcomes. Several mental health parameters such as depression, anxiety, and quality of life were also assessed over the course of pregnancy, and we are specifically investigating how mental health interacts with chronic medical conditions such as asthma in pregnant women. |
COGNITIVE FUNCTION AND MOOD DISORDERS STUDY (CoFaMS) The CoFaMS project (Principal investigator: Professor Bernhard Baune) investigates the relationship between mood- and anxiety disorders and cognitive outcomes such as memory, attention, or planning ability. We are also investigating the biological underpinnings of mood disorder symptoms and responses to treatments through genetic, transcriptomic, and proteomic analyses of participant’s blood samples. Currently, >250 participants have been assessed for the CoFaMS project in South Australia. |
COGNITIVE AND AND FUNCTIONAL ASSESSMENTS IN PSYCHOSIS STAGING STUDY (CoFAPSS) The CoFAPSS project (Principal investigator: Professor Bernhard Baune) investigates the longitudinal development of psychotic symptoms, neurocognitive symptoms, and functional outcomes in people who are suffering from a psychotic disorder such as schizophrenia, schizoaffective disorder, or bipolar disorder. In order to better understand the biological drivers of disease progression in psychotic disorders, we are also collecting participant’s blood samples for genetic, transcriptomic, and proteomic analyses. |
TRAJECTORIES OF RESPONSE TO ARIPIPRAZOLE MAINTENA STUDY (TRAMS) This investigator-initiated naturalistic clinical study (Principal Investigator: Professor Bernhard Baune), supported by the Lundbeck Institute, enrolls patients with psychotic disorders such as schizophrenia or schizoaffective disorder who are treated with the recently available depot antipsychotic aripipazole maintena. The study assesses patient’s psychotic symptoms as well as their cognitive- and everyday functioning before and during the first year of treatment. |
-
Appointments
Date Position Institution name 2018 - ongoing Clinical Associate Professor University of Adelaide 2016 - 2017 Clinical Senior Lecturer The University of Adelaide 2013 - 2016 Clinical Academic The University of Adelaide 2013 - ongoing Consultant Psychiatrist Northern Mental Health -
Awards and Achievements
Date Type Title Institution Name Country Amount 2015 Award Young Investigator Award International Congress on Schizophrenia Research (ICOSR) United States - 2013 Award Prof. Derek Frewin Citation for Clinical Teaching 2013 School of Medicine, The University of Adelaide Australia - 2012 Award Prof. Derek Frewin Citation for Clinical Teaching 2012 School of Medicine, The University of Adelaide Australia - 2008 Fellowship Molecular Medicine Ireland Clinician Scientist Fellowship Molecular Medicine Ireland (MMI)/ Royal College of Surgeons in Ireland Ireland EUR 180,000 -
Education
Date Institution name Country Title 2013 Royal Australian and New Zealand College of Psychiatry Australia FRANZCP 2011 The College of Psychiatry of Ireland Ireland Certificate of Satisfactory Completion of Specialist Training (CSCST) 2009 The Institute for Commercial Management United Kingdom Postgraduate Diploma in Health Service Management 2008 - 2014 Royal College of Surgeons in Ireland Ireland PhD 2008 Royal College of Psychiatrists United Kingdom MRCPsych 2000 - 2005 Institute for Anatomy and Cell Biology, University of Freiburg Germany Doctor of Medicine (MD) 1998 - 2004 University of Freiburg Germany State Exam Medicine -
Research Interests
-
Journals
Year Citation 2024 Kavakbasi, E., Sampson, E., Mills, N. T., Hori, H., Schwarte, K., Hohoff, C., . . . Baune, B. T. (2024). Inflammation-stratified augmentation of vortioxetine with celecoxib: Results from a double-blind, randomized, placebo-controlled trial in major depressive disorder. Journal of Neurochemistry, 168(9), 1817-1825.
Scopus3 Europe PMC22024 Froessler, B., Clarke, L., & Schubert, K. O. (2024). Quality of recovery following childbirth: a missing element. Anaesthesia, 79(2), 211-212.
Scopus1 WoS12024 Ou, A. H., Rosenthal, S. B., Adli, M., Akiyama, K., Akula, N., Alda, M., . . . Kelsoe, J. R. (2024). Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study. Translational Psychiatry, 14(1), 109-1-109-9.
Scopus3 Europe PMC32024 Sampson, E., Kavakbasi, E., Mills, N. T., Hori, H., Schubert, K. O., Fourrier, C., & Baune, B. T. (2024). Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib. International Journal of Neuropsychopharmacology, 27(3), 11 pages.
2024 Morgan, J. A., Bednarz, J. M., Semo, R., Clark, S. R., & Schubert, K. O. (2024). Long-term recreational exercise patterns in adolescents and young adults: Trajectory predictors and associations with health, mental-health, and educational outcomes. PLoS ONE, 19(3 March), 24 pages.
2024 Herrera-Rivero, M., Gutiérrez-Fragoso, K., Thalamuthu, A., Amare, A. T., Adli, M., Akiyama, K., . . . Baune, B. T. (2024). Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder. Translational Psychiatry, 14(1), 174-1-174-10.
Scopus3 Europe PMC32024 Patrickson, B., Shams, L., Fouyaxis, J., Strobel, J., Schubert, K. O., Musker, M., & Bidargaddi, N. (2024). Evolving Adult ADHD Care: Preparatory Evaluation of a Prototype Digital Service Model Innovation for ADHD Care. International Journal of Environmental Research and Public Health, 21(5), 582.
2024 Stainton, A., Bryce, S., Rattray, A., Pert, A., Zbukvic, I., Fisher, E., . . . Allott, K. (2024). Validating cognitive screening in young people with first-episode psychosis: The CogScreen protocol. Early Intervention in Psychiatry, 8 pages.
2024 Herrera-Rivero, M., Adli, M., Akiyama, K., Akula, N., Amare, A. T., Ardau, R., . . . Baune, B. T. (2024). Exploring the genetics of lithium response in bipolar disorders. International Journal of Bipolar Disorders, 12(1), 20-1-20-11.
Europe PMC12024 Sharew, N. T., Clark, S. R., Schubert, K. O., & Amare, A. T. (2024). Pharmacogenomic scores in psychiatry: systematic review of current evidence. Translational Psychiatry, 14(1), 322-1-322-16.
2024 Martin, J. C., Clark, S. R., Hartmann, S., & Schubert, K. O. (2024). A Tale of Three Spectra: Basic Symptoms in Clinical-High-Risk of Psychosis Vary Across Autism Spectrum Disorder, Schizotypal Personality Disorder, and Borderline Personality Disorder. Schizophrenia Bulletin Open, 5(1), sgae017.
Scopus12023 Amare, A. T., Thalamuthu, A., Schubert, K. O., Fullerton, J. M., Ahmed, M., Hartmann, S., . . . Baune, B. T. (2023). Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder. Molecular Psychiatry, 28(12), 5251-5261.
Scopus9 WoS2 Europe PMC132023 Sampson, E., Mills, N. T., Hori, H., Schwarte, K., Hohoff, C., Schubert, K. O., . . . Baune, B. T. (2023). Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Clinical Psychiatry, 84(6), 14 pages.
Scopus1 Europe PMC12023 Kelsoe, J., Ou, A., Rosenthal, S., Adli, M., Akiyama, K., Akula, N., . . . Zompo, M. D. (2023). Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study.. Res Sq.
2023 Morgan, J., Bednarz, J., Semo, R., Clark, S., & Schubert, O. (2023). Predictors of long-term recreational exercise participation in adolescents and young adults.
2023 Martin, J. C., Clark, S. R., & Schubert, K. O. (2023). Towards a Neurophenomenological Understanding of Self-Disorder in Schizophrenia Spectrum Disorders: A Systematic Review and Synthesis of Anatomical, Physiological, and Neurocognitive Findings. Brain Sciences, 13(6), 21 pages.
Scopus4 Europe PMC12023 Froessler, B., Schubert, K. O., Palm, P., Church, R., Aboustate, N., Kelly, T., . . . Hodyl, N. A. (2023). Testing equivalence of two doses of intravenous iron to treat iron deficiency in pregnancy: A randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology, 130(1), 15-23.
Scopus3 WoS1 Europe PMC32022 Baune, B. T., Sampson, E., Louise, J., Hori, H., Schubert, K. O., Clark, S. R., . . . Fourrier, C. (2022). Corrigendum to 'No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial' [European Neuropsychopharmacology 53 (2021) 34-46].. Eur Neuropsychopharmacol, 64, 61-62.
2022 Ciobanu, L. G., Stankov, L., Schubert, K. O., Amare, A. T., Jawahar, M. C., Lawrence-Wood, E., . . . Aidman, E. (2022). General intelligence and executive functioning are overlapping but separable at genetic and molecular pathway levels: An analytical review of existing GWAS findings. PLOS ONE, 17(10), e0272368.
Scopus2 Europe PMC12022 Aldridge, E., Schubert, K. O., Pathirana, M., Sierp, S., Leemaqz, S. Y., Roberts, C. T., . . . Arstall, M. A. (2022). A prospective registry analysis of psychosocial and metabolic health between women with and without metabolic syndrome after a complicated pregnancy. BMC Women's Health, 22(1), 1-9.
2022 Cearns, M., Amare, A. T., Schubert, K. O., Thalamuthu, A., Frank, J., Streit, F., . . . Baune, B. T. (2022). Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach. The British Journal of Psychiatry, 220(4), 219-228.
Scopus14 WoS8 Europe PMC72022 Cearns, M., Amare, A. T., Schubert, K. O., Thalamuthu, A., Frank, J., Streit, F., . . . Stamm, T. (2022). Erratum: Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: Machine learning approach (The British Journal of Psychiatry (2022) (1–10) DOI: 10.1192/bjp.2022.28). British Journal of Psychiatry, 221(2), 494.
Scopus2 Europe PMC22022 Schubert, K. O., Thalamuthu, A., Amare, A. T., Frank, J., Streit, F., Adl, M., . . . Baune, B. T. (2022). Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.. Translational psychiatry, 12(1), 278.
WoS12022 Thalamuthu, A., Mills, N. T., Berger, K., Minnerup, H., Grotegerd, D., Dannlowski, U., . . . Baune, B. T. (2022). Genome-wide interaction study with major depression identifies novel variants associated with cognitive function.. Mol Psychiatry, 27(2), 1111-1119.
Scopus30 WoS15 Europe PMC192021 Coombes, B. J., Millischer, V., Batzler, A., Larrabee, B., Hou, L., Papiol, S., . . . Biernacka, J. M. (2021). Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study. Complex Psychiatry, 7(3-4), 80-89.
Scopus9 Europe PMC82021 Schubert, K. O., Thalamuthu, A., Amare, A. T., Frank, J., Streit, F., Adl, M., . . . Baune, B. T. (2021). Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. Translational Psychiatry, 11(1), 100-108.
Scopus31 WoS15 Europe PMC182021 Amare, A., Schubert, K. O., Thalamuthu, A., Clark, S., Schulze, T. G., Rietschel, M., & Baune, B. (2021). TH69. COMBINING SCHIZOPHRENIA AND DEPRESSION POLYGENIC RISK SCORES (PRS) IMPROVES THE GENETIC PREDICTION OF LITHIUM RESPONSE IN BIPOLAR DISORDER PATIENTS. European Neuropsychopharmacology, 51, e231.
2021 Miles, A. E., Dos Santos, F. C., Byrne, E. M., Renteria, M. E., McIntosh, A. M., Adams, M. J., . . . Nikolova, Y. S. (2021). Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk. Neuropsychopharmacology, 46(13), 2304-2311.
Scopus6 WoS2 Europe PMC42021 Amare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Cearns, M., . . . Binder, E. B. (2021). Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Molecular Psychiatry, 26(6), 2457-2470.
Scopus42 WoS39 Europe PMC302021 Kalman, J. L., Olde Loohuis, L. M., Vreeker, A., McQuillin, A., Stahl, E. A., Ruderfer, D., . . . Ophoff, R. A. (2021). Characterisation of age and polarity at onset in bipolar disorder. The British Journal of Psychiatry, 219(6), 659-669.
Scopus19 WoS8 Europe PMC122021 Le Clerc, S., Lombardi, L., Baune, B. T., Amare, A. T., Schubert, K. O., Hou, L., . . . Tamouza, R. (2021). HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. Scientific Reports, 11(1), 17823-1-17823-12.
Scopus11 WoS6 Europe PMC102021 Jernbom Falk, A., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2021). Autoantibody profiles associated with clinical features in psychotic disorders. Translational Psychiatry, 11(1), 1-9.
Scopus11 WoS7 Europe PMC62021 Bidargaddi, N., Schrader, G., Myles, H., Schubert, K. O., van Kasteren, Y., Zhang, T., . . . Strobel, J. (2021). Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illness. Australian and New Zealand Journal of Psychiatry, 55(10), 976-982.
Scopus8 WoS6 Europe PMC52021 Kalman, J., Clark, S., Baune, B., Schubert, K. O., Schulze, T., & Ophoff, R. (2021). Characterization of Age and Polarity at Onset in Bipolar Disorder. medRxiv.
2021 Baune, B. T., Sampson, E., Louise, J., Hori, H., Schubert, K. O., Clark, S. R., . . . Fourrier, C. (2021). No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial.. Eur Neuropsychopharmacol, 53, 34-46.
Scopus34 WoS16 Europe PMC212020 Fourrier, C., Sampson, E., Hori, H., Schubert, K. O., Clark, S., Mills, N. T., & Baune, B. T. (2020). Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status. Brain, Behavior, and Immunity, 88, 242-251.
Scopus10 WoS7 Europe PMC62020 Zulfic, Z., Liu, D., Lloyd, C., Rowan, J., & Schubert, K. O. (2020). Is telepsychiatry care a realistic option for community mental health services during the COVID-19 pandemic?. Australian and New Zealand Journal of Psychiatry, 54(12), 1228.
Scopus19 WoS15 Europe PMC112020 Thomson, S., Doan, T., Liu, D., Schubert, K. O., Toh, J., Boyd, M. A., & Galletly, C. (2020). Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic. Australasian Psychiatry, 28(5), 492-499.
Scopus14 WoS13 Europe PMC92020 Scott, J., Etain, B., Manchia, M., Brichant-Petitjean, C., Geffory, P., Schulze, T., . . . Schubert, K. (2020). An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes. Bipolar Disorders, 22(3), 255-265.
Scopus29 WoS21 Europe PMC162020 Soda, T., McLoughlin, D. M., Clark, S. R., Oltedal, L., Kessler, U., Haavik, J., . . . Baune, B. T. (2020). International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic).. Eur Arch Psychiatry Clin Neurosci, 270(7), 921-932.
Scopus21 WoS17 Europe PMC132020 Ciobanu, L. G., Sachdev, P. S., Trollor, J. N., Reppermund, S., Thalamuthu, A., Mather, K. A., . . . Baune, B. T. (2020). Downregulated transferrin receptor in the blood predicts recurrent MDD in the elderly cohort: a fuzzy forests approach. Journal of Affective Disorders, 267, 42-48.
Scopus10 WoS9 Europe PMC62019 Janos, K., Serg, P., Clark, S. R., Schubert, K. O., Baune, B. T., & Schulze, T. (2019). Investigating polygenic burden in age at disease onset in bipolar disorder: findings from an international multicentric study.. Bipolar Disorders, 21(1), 68-75.
Scopus21 WoS16 Europe PMC142019 Amare, A. T., Schubert, K. O., Tekola-Ayele, F., Hsu, Y. H., Sangkuhl, K., Jenkins, G., . . . Baune, B. T. (2019). The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression. Journal of Neural Transmission, 126(1), 35-45.
Scopus25 WoS19 Europe PMC162018 Stacey, D., Schubert, K., Clark, S., Amare, A., Milanesi, E., Maj, C., . . . Baune, B. (2018). A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder. Translational Psychiatry, 8(1), 183-1-183-11.
Scopus24 WoS11 Europe PMC152018 Schubert, K., Stacey, D., Arentz, G., Clark, S., Air, T., Hoffmann, P., & Baune, B. (2018). Targeted proteomic analysis of cognitive dysfunction in remitted major depressive disorder: Opportunities of multi-omics approaches towards predictive, preventive, and personalized psychiatry. Journal of Proteomics, 188, 63-70.
Scopus21 WoS13 Europe PMC112018 Amare, A., Schubert, K., Tekola-Ayele, F., Hsu, Y., Sangkuhl, K., Jenkins, G., . . . Baune, B. (2018). Association of the polygenic scores for personality traits and response to selective serotonin reuptake inhibitors in patients with major depressive disorder. Frontiers in Psychiatry, 9(MAR), 65-1-65-11.
Scopus39 WoS28 Europe PMC172018 Reinbold, C. S., Clark, S. R., Schubert, K. O., Baune, B. T., & Cichon, S. (2018). Analysis of the influence of microRNAs in Lithium Response in Bipolar Disorder. Frontiers in Psychiatry, 9(MAY), 207-1-207-9.
Scopus31 WoS23 Europe PMC172018 Amare, A., Schubert, K., Hou, L., Clark, S., Papiol, S., Heilbronner, U., . . . Baune, B. (2018). Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide association study. JAMA psychiatry, 75(1), 65-74.
Scopus141 WoS103 Europe PMC822018 Schubert, K. O., & Wisdom, A. (2018). Should the Australian Therapeutic Goods Administration recommend rapid dosing of lithium carbonate in acute mania?. Australian and New Zealand Journal of Psychiatry, 52(4), 387.
Scopus2 WoS2 Europe PMC22018 Ciobanu, L. G., Sachdev, P. S., Trollor, J. N., Reppermund, S., Thalamuthu, A., Mather, K. A., . . . Baune, B. T. (2018). Co-expression network analysis of peripheral blood transcriptome identifies dysregulated protein processing in endoplasmic reticulum and immune response in recurrent MDD in older adults. Journal of Psychiatric Research, 107, 19-27.
Scopus24 WoS18 Europe PMC132018 Amare, A., Oliver Schubert, K., Hou, L., Clark, S., Papiol, S., Cearns, M., . . . Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. (2018). Polygenic scores for major depressive disorder and depressive symptoms predict response to lithium in patients with bipolar disorder.
2018 Clark, S. R., Schubert, K. O., Olagunju, A. T., Lyrtzis, E. A., & Baune, B. T. (2018). Cognitive and Functional Assessment of Psychosis Stratification Study (CoFAPSS): Rationale, Design, and Characteristics. Frontiers in Psychiatry, 9, 10 pages.
Scopus1 Europe PMC12017 Schubert, K., Air, T., Clark, S., Grzeskowiak, L., Miller, E., Dekker, G., . . . Clifton, V. (2017). Trajectories of anxiety and health related quality of life during pregnancy. PLoS ONE, 12(7), e0181149-1-e0181149-14.
Scopus37 WoS28 Europe PMC212017 Amare, A., Schubert, K., & Baune, B. (2017). Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry. EPMA Journal, 8(3), 211-227.
Scopus75 WoS62 Europe PMC442017 Clark, S., Schubert, K., & Baune, B. (2017). How Early Can We Predict and Prevent Psychosis?. Australasian Science, 38(4), 36-37. 2017 Amare, A., Schubert, K. O., Hou, L., Clark, S., Papiol, S., Heilbronner, U., . . . Baune, B. (2017). High genetic loading of schizophrenia predicts poor response to lithium in patients with bipolar disorder: A polygenic score and cross-trait genetic analysis. biorxiv, 48 pages.
2017 Clark, S., Warren, N., Kim, G., Jankowiak, D., Schubert, K., Kisely, S., . . . Siskind, D. (2017). Elevated clozapine levels associated with infection: a systematic review. Schizophrenia Research, 192, 50-56.
Scopus121 WoS73 Europe PMC482017 Clark, S., Amminger, P., Lin, A., Schubert, K. O., Pantelis, C., Yung, A., . . . Nelson, B. (2017). PROBABILISTIC MODELING OF TRANSITION TO PSYCHOSIS USING CLINICAL AND COGNITIVE VARIABLES IN THE PERSONAL ASSESSMENT AND CRISIS EVALUATION ("PACE 400") STUDY. SCHIZOPHRENIA BULLETIN, 43, S101. 2017 Schubert, K. O., Clark, S. R., Van, L. K., Collinson, J. L., & Baune, B. T. (2017). Depressive symptom trajectories in late adolescence and early adulthood: A systematic review. Australian and New Zealand Journal of Psychiatry, 51(5), 477-499.
Scopus91 WoS69 Europe PMC432017 Grzeskowiak, L., Smith, B., Roy, A., Schubert, K., Baune, B., Dekker, G., & Clifton, V. (2017). Impact of a history of maternal depression and anxiety on asthma control during pregnancy. Journal of Asthma, 54(7), 706-713.
Scopus27 WoS18 Europe PMC102017 Amare, A., Schubert, K., Klingler-Hoffmann, M., Cohen-Woods, S., & Baune, B. (2017). The genetic overlap between mood disorders and cardiometabolic diseases: A systematic review of genome wide and candidate gene studies. Translational Psychiatry, 7(1), 1-12.
Scopus245 WoS192 Europe PMC1402016 Schubert, K., Weiland, F., Baune, B., & Hoffmann, P. (2016). The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: a review. Proteomics, 16(11-12), 1747-1758.
Scopus38 WoS27 Europe PMC202016 Clark, S., Baune, B., Schubert, K., Lavoie, S., Smesny, S., Rice, S., . . . Amminger, G. (2016). Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers. Translational Psychiatry, 6(9), 1-8.
Scopus53 WoS46 Europe PMC242016 Schubert, K., Foecking, M., Wynne, K., & Cotter, D. (2016). Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus. Proteomics, 16(3), 532-538.
Scopus6 WoS5 Europe PMC52016 Hou, L., Heilbronner, U., Degenhardt, F., Adli, M., Akiyama, K., Akula, N., . . . Schulze, T. (2016). Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. The Lancet, 387(10023), 1085-1093.
Scopus271 WoS221 Europe PMC1562016 Schubert, K., Stacey, D., Air, T., & Baune, B. (2016). Peripheral blood gene expression analysis implicates B lymphocyte proliferation and ribosomal S26 transcripts in cognitive dysfunction in people with remitted Major Depression. Journal of Affective Disorders, 190, 754-756.
Scopus5 WoS5 Europe PMC32015 Jaehne, E., Ramshaw, H., Xu, X., Saleh, E., Clark, S., Schubert, K., . . . Baune, B. (2015). In-vivo administration of clozapine affects behaviour but does not reverse dendritic spine deficits in the 14-3-3ζ KO mouse model of schizophrenia-like disorders. Pharmacology Biochemistry and Behavior, 138, 1-8.
Scopus13 WoS10 Europe PMC82015 Baune, B., Clark, S., Schubert, O., Rice, S., Vijayakumar, N., Schaefer, M., . . . Amminger, P. (2015). Oxidative Markers for Prediction of Transition to Psychosis From the Clinical High-risk State. EUROPEAN PSYCHIATRY, 30, 1 page.
2015 Baune, B., Schubert, O., & Clark, S. (2015). Indicated Prevention in Clinical High Risk (Chr) for First Episode Psychosis (Fep): the Utility of an Extended Diagnostic Approach.. EUROPEAN PSYCHIATRY, 30, 1 page.
WoS12015 Clark, S., Schubert, K., & Baune, B. (2015). Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome. Journal of Neural Transmission, 122(1), 155-169.
Scopus31 WoS29 Europe PMC142015 Oliver Schubert, K., Clark, S., & Baune, B. (2015). The use of clinical and biological characteristics to predict outcome following First Episode Psychosis. Australian and New Zealand Journal of Psychiatry, 49(1), 24-35.
Scopus28 WoS25 Europe PMC172015 Schubert, K., Föcking, M., & Cotter, D. (2015). Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology. Schizophrenia Research, 167(1-3), 64-72.
Scopus65 WoS58 Europe PMC482015 McGorry, P. D. (2015). Australian Early Psychosis Research Network: national collaboration, international competitive advantage. The Medical Journal of Australia, 202(4), 170-171.
2015 Clark, S. R., Schubert, K. O., & Baune, B. T. (2015). PROBABILISTIC ASSESSMENTS OF TRANSITION RISK IN THE PSYCHOSIS PRODROME. SCHIZOPHRENIA BULLETIN, 41(suppl 1), S14-S15.
2013 Manchia, M., & Baune, B. (2013). Assessment of response to lithium maintenance treatment in bipolar disorder: a consortium on lithium genetics (ConLiGen) report. PLoS One, 8(6), 1-9.
Scopus141 WoS120 Europe PMC872012 Schubert, K., Föcking, M., Prehn, J., & Cotter, D. (2012). Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?. Molecular Psychiatry, 17(7), 669-681.
Scopus73 WoS62 Europe PMC482011 Föcking, M., Dicker, P., English, J., Schubert, K., Dunn, M., & Cotter, D. (2011). Common Proteomic Changes in the Hippocampus in Schizophrenia and Bipolar Disorder and Particular Evidence for Involvement of Cornu Ammonis Regions 2 and 3. Archives of General Psychiatry, 68(5), 477-488.
Scopus84 Europe PMC682009 Schubert, K. O., English, J. A., & Cotter, D. R. (2009). An update on the Neuropathology of Schizophrenia. Advances in Schizophrenia and Clinical Psychiatry, 4(2), 38-44. 2006 Naumann, T., Steup, A., Schnell, O., Schubert, K. O., Zhi, Q., Guijarro, C., . . . Hofmann, H. D. (2006). Altered neuronal responses and regulation of neurotrophic proteins in the medial septum following fimbria-fornix transection in CNTF- and leukaemia inhibitory factor-deficient mice. European Journal of Neuroscience, 24(8), 2223-2232.
Scopus5 Europe PMC52005 Schubert, K. O., Naumann, T., Schnell, O., Zhi, Q., Steup, A., Hofmann, H. D., & Kirsch, M. (2005). Activation of STAT3 signaling in axotomized neurons and reactive astrocytes after fimbria-fornix transection. Experimental Brain Research, 165(4), 520-531.
Scopus11 Europe PMC102003 Naumann, T., Schnell, O., Zhi, Q., Kirsch, M., Schubert, K. O., Sendtner, M., & Hofmann, H. D. (2003). Endogenous ciliary neurotrophic factor protects GABAergic, but not cholinergic, septohippocampal neurons following fimbria-fornix transection. Brain Pathology, 13(3), 309-321.
Scopus25 Europe PMC18 -
Book Chapters
Year Citation 2020 Clark, S. R., Cearns, M., Schubert, K. O., & Baune, B. (2020). Multimodal modeling for personalized psychiatry. In B. Baune (Ed.), Personalised Psychiatry (1st ed., pp. 521-536). London, United Kingdom: Academic Press.
DOI Scopus22020 Clark, S. R., Schubert, K. O., & Baune, B. (2020). The modeling of trajectories in psychotic illness. In B. Baune (Ed.), Personalized Psychiatry (1st ed., pp. 3-12). London, United Kingdom: Academic Press.
DOI2020 Schubert, K. O., Clark, S. R., Van, L. K., Collinson, J. L., & Baune, B. T. (2020). Mood trajectories as a basis for personalized psychiatry in young people. In B. T. Baune (Ed.), Personalized Psychiatry (pp. 13-26). London, United Kingdom: Academic Press.
DOI2020 Cotter, D. R., Sabherwal, S., & Schubert, K. O. (2020). Proteomics for diagnostic and therapeutic blood biomarker discovery in schizophrenia and other psychotic disorders. In B. Baune (Ed.), Personalized Psychiatry (pp. 307-317). London, United Kingdom: Academic Press.
DOI Scopus22016 Amare, A., Schubert., & Baune. (2016). Genetic Overlap Between Depression and Cardiometabolic Disorders. In Baune, & Tully (Eds.), Cardiovascular Diseases and Depression Treatment and Prevention in Psychocardiology (pp. 235-255). Switzerland: Springer.
DOI2016 Schubert. (2016). Chapter 2. In D. Browne, & S. M. Pillay (Eds.), Master Pass Mcqs for the New Mrcpsych Paper a With Answers Explained. CRC Press. -
Conference Papers
Year Citation 2022 Hussain, S., Price, G., McAndrew, M., Bose, A., Rodger, J., Hennessy, L. A., . . . McFarlane, A. (2022). REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS), ELECTROENCEPHALOGRAPHY (EEG) AND CONNECTOMES: A CLINICAL AND TECHNICAL UPDATE. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 56 (pp. 115-116). SAGE PUBLICATIONS LTD. 2021 Schubert, K. O., Falk, A. J., Galletly, C., Just, D., Toben, C., Baune, B., . . . Manberg, A. (2021). Autoantibody profiles are associated with specific clinical features in psychotic disorders. In EUROPEAN PSYCHIATRY Vol. 64 (pp. S765-S766). CAMBRIDGE UNIV PRESS.
DOI2017 Schubert, K. O., Baune, B. T., & Froessler, B. (2017). INCREASING MENTAL HEALTH RESEARCH IMPACT WITHIN GENERAL HOSPITAL SETTINGS THROUGH COLLABORATIVE PROJECTS WITH OTHER MEDICAL DISCIPLINES. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 51 (pp. 22). SAGE PUBLICATIONS LTD. 2017 Baune, B., Amare, A., Schubert, K. O., & Biernacka, J. (2017). POLYGENIC SCORE FOR CARDIOMETABOLIC AND PSYCHIATRIC PHENOTYPES PREDICT RESPONSE TO TREATMENT WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN MAJOR DEPRESSIVE DISORDER. In EUROPEAN NEUROPSYCHOPHARMACOLOGY Vol. 27 (pp. S512-S513). Jerusalem, ISRAEL: ELSEVIER SCIENCE BV.
DOI -
Conference Items
Year Citation 2023 Arthurs, E., Goldsworthy, M., Sokolenko, E., Schubert, K. O., Tan, K. T., Bol, D., & Clark, S. (2023). Frontal Alpha Asymmetry as a Biomarker of Symptoms, Cognition, and Function in Mood Disorders. Poster session presented at the meeting of Society for Social and Affective Neuroscience. Adelaide. 2023 Schubert, K. O., Pathirana, M., FUGARO, P., Onf, H., Fenech, D., GUIDOLIN, M., . . . Wright, S. (2023). EXTERNAL AND SERVICE FACTORS INFLUENCING OUTCOMES IN A MODEL OF STRATIFIED MENTAL HEALTH SERVICES FOR YOUNG PEOPLE. Poster session presented at the meeting of International Conference on Early Intervention 14. Luscerne, Switzerland. 2022 Amare, A., Thalamuthu, A., Schubert, K. O., McMahon, F. J., Schulze, T. G., Clark, S., & Baune, B. (2022). POLYGENIC SCORE IDENTIFIES BIPOLAR PATIENTS ULTRA-RESPONSIVE TO LITHIUM TREATMENT. Poster session presented at the meeting of European Neuropsychopharmacology. Florence, Italy: Elsevier BV.
DOI2022 Tan, K. T., Lawrence, A., Lawrence-Wood, E., Edwards, S., Rogasch, N., Schubert, K. O., . . . McFarlane, A. (2022). TRAUMA HISTORY IS ASSOCIATED WITH A 1/F ELECTROENCEPHALOGRAPHY (EEG) SIGNATURE IN A MILITARY SAMPLE. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. 2022 Falk, A. J., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2022). BEYOND NEURORECEPTOR AUTOIMMUNITY: PERIPHERAL AUTOANTIBODY PROFILES ARE ASSOCIATED WITH CLINICAL FEATURES IN PSYCHOTIC DISORDERS. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. Sydney, NSW: SAGE PUBLICATIONS LTD. 2021 Ciobanu, L., Stankov, L., Heathcote, A., Clark, S., Breen, J., Rogasch, N., . . . Aidman, E. (2021). Mapping the genetic architectures of cognitive functioning. Poster session presented at the meeting of GeneMappers 2021. Virtual. 2020 Ciobanu, L., Schubert, K. O., Amare, A., Jawahar, C., Mills, N., Knight, M., . . . Aidman, E. (2020). Genetic Pathways of Cognitive Performance are Overlapping but Distinct for General Intelligence and Executive Functioning Tasks. Poster session presented at the meeting of 2020 Virtual World Congress of Psychiatric Genetics. Virtual. 2020 Ciobanu, L., Schubert, K. O., Amare, A., Jawahar, C., Lawrence-Woods, E., Knight, M., . . . Aidman, E. (2020). Genetic Markers of Cognitive Fitness. Poster session presented at the meeting of Defence Human Sciences Symposium 2020. online. 2019 Clark, S., Stacey, D., Schubert, K. O., & Baune, B. T. (2019). Transcriptomic analyses on the biological underpinnings of lithium treatment response. Poster session presented at the meeting of 14th world cpngress of biological psychiatry. Vancouver. 2018 Clark, S. R., Schubert, K. O., Opel, N., Amminger, G. P., Lin, A., Pantelis, C., . . . Baune, B. T. (2018). Prediction Modelling in Psychosis: A Comparison of Simple Bayesian and Support Vector Machine Techniques.. Poster session presented at the meeting of The Human Brain Proteome Project (HBPP) Workshop 2018. Adelaide. 2018 Clark, S. R., Schubert, K. O., & Baune, B. T. (2018). Bayesian Prediction Modelling in Psychosis. Poster session presented at the meeting of World Psychiatry Association 2018 Thematic Congress. Melbourne. 2018 Clark, S., Schubert, K., Olagunju, A., Lyrtzis, E., Watson, D., & Baune, B. (2018). Trajectories in response to Aripiprazole Maintena Study: Six-month follow-up. Poster session presented at the meeting of Abstracts of the Australia and New Zealand College of Psychiatrists Congress (RANZCP 2018), as published in Australia and New Zealand Journal of Psychiatry. Auckland, New Zealand: Sage Publications.
DOI WoS22018 Clark, S. (2018). Writing a Successful RANZCP Grant. Poster session presented at the meeting of Abstracts of the Australia and New Zealand College of Psychiatrists Congress (RANZCP 2018), as published in Australia and New Zealand Journal of Psychiatry. Auckland, New Zealand: Sage Publications.
DOI2017 Clark, S. R., schubert, K. O., Olagunju, A. T., Lyrtzis, E., Watson, D., & Baune, B. T. (2017). Trajectories in response to Aripiprazole Maintena Study (TRAMS). Poster session presented at the meeting of Society for Mental Health Research Conference 2017. Canberra. 2017 Schubert, K. O., Stacey, D., Arentz., Hoffmann., & Baune. (2017). Using a Correlational Systems Biology Approach in Gene Expression and Proteomic Discovery Platforms, to characterize Cognitive Dysfunction in people with remitted Major Depression. Poster session presented at the meeting of EUROPEAN NEUROPSYCHOPHARMACOLOGY. Jerusalem, Israel: ELSEVIER SCIENCE BV.
DOI WoS12016 Schubert, K. O., Stacey., Arentz., Hoffmann., & Baune. (2016). Gene expression and Proteomic Analysis of Cognitive Dysfunction in People with Remitted Major Depression.. Poster session presented at the meeting of 15th Human Proteome Organization World Congress. Taipei, Taiwan. 2016 Schubert, K. O., Stacey., Arentz., Hoffmann., & Baune. (2016). Peripheral blood gene expression and proteomic analysis implicates B-cell development and ribosomal proteins in cognitive dysfunction in people with remitted Major Depression.. Poster session presented at the meeting of Human Brain Proteome Project (HBPP) Workshop. Stockholm, Sweden. 2016 Clark, S. R., Amminger, G. P., Lin, A., Schubert, K. O., Yung, A., Wood, S., . . . Nelson, B. (2016). Prediction of transition to psychosis in the PACE 400 sample using a probabilistic model. Poster session presented at the meeting of Society for Mental Health Research Conference. Sydney. 2015 Clark, S. R., Schubert, K. O., Rice, S., Vijayakumar, N., Schäfer, M., McGorry, P. D., . . . Amminger, G. P. (2015). Can we predict psychosis in a frontline clinical setting?. Poster session presented at the meeting of Australasian Schizophrenia Conference. Melbourne. 2015 Schubert, K. O., Wylde, C. P., Clark, S. R., & Baune, B. T. (2015). Are Deficits in the Verbal Comprehension Index (VCI) of the Wechsler Adult Intelligence Scale (WAIS) associated with clinical and functional outcomes in Schizophrenia?. Poster session presented at the meeting of Australasian Schizophrenia Conference 2015. Melbourne. 2015 Schubert, K. O., Stacey, D., Arentz, G., Hoffmann, P., & Baune, B. T. (2015). Peripheral blood gene expression and proteomic analysis implicates B-cell development and ribosomal proteins in cognitive dysfunction in people with remitted Major Depression. Poster session presented at the meeting of Society for Mental Health Research Conference 2015. Brisbane. 2015 Clark, S. R., Kim, G., Jankowiak, D., Schubert, K. O., & Baune, B. T. (2015). Multiple mechanisms of clozapine toxicity related to infection. Poster session presented at the meeting of Society of Mental Health Research Conference 2015. Brisbane. 2015 Schubert, K. O., Foecking, M., & Cotter, D. R. (2015). PROTEOMIC PATHWAY ANALYSIS OF THE HIPPOCAMPUS IN SCHIZOPHRENIA AND BIPOLAR AFFECTIVE DISORDER IMPLICATES 14-3-3 SIGNALING, ARYL HYDROCARBON RECEPTOR SIGNALING, AND GLUCOSE METABOLISM.. Poster session presented at the meeting of SCHIZOPHRENIA BULLETIN. Colorado Springs, CO: OXFORD UNIV PRESS.
DOI2014 Schubert, K. O., Higgs, L., McKay, S., Baune, B. T., Clark, S. R., Rafalowicz, E., . . . Mylvaganam, S. (2014). EPIS North: a consultation-based Early Psychosis Intervention Programme supporting a general adult community mental health service.. Poster session presented at the meeting of Society for Mental Health Research (SMHR) Annual Conference. Adelaide. 2014 Schubert, K. O. (2014). Destigmatising long acting injectables in the eyes of the carers and families. Poster session presented at the meeting of Society for Mental Health Research (SMHR) Annual Conference. Adelaide. 2014 Clark, S. R., Baune, B. T., Schubert, K. O., Rice, S., Vijayakumar, N., Schäfer, M. R., . . . Amminger, G. P. (2014). Modeling trajectories in clinical high risk of psychosis. Poster session presented at the meeting of Society for Mental Health Research. Adelaide. 2014 Clark, S. R., Wilton, L., Donohoe, P., Schubert, K. O., & Baune, B. T. (2014). General Practice based public-private clozapine monitoring.. Poster session presented at the meeting of Society for Mental Health Research. Adelaide. 2011 Schubert, K. O., Foecking, M., & Cotter, D. R. (2011). Does dysfunction of clathrin mediated endocytosis contribute to synaptic pathology in psychotic disorders? A review of the evidence?. Poster session presented at the meeting of Advancing Drug Discovery for Schizophrenia, New York Academy of Science. New York. 2010 Schubert, K. O., Föcking, M., Dicker, P., Dunn, M. J., & Cotter, D. R. (2010). PROTEOMIC ANALYSIS OF THE BASIC SUB-PROTEOME (PH 6-11) IN THE HIPPOCAMPUS IN SCHIZOPHRENIA AND BIPOLAR AFFECTIVE DISORDER. Poster session presented at the meeting of Schizophrenia Research. Elsevier BV.
DOI2008 Schubert, K. O., Foecking, M., Dicker, P., Hudson, L., Dunn, M. J., & Cotter, D. (2008). Proteomic and western blot analysis of hippocampal subregions in schizophrenia and bipolar disorder.. Poster session presented at the meeting of The Schizophrenia International Research Society Conference. Venice, Italy. 2008 Schubert, K. O., Foecking, M., Prehn, J. H., & Cotter, D. R. (2008). Differential hippocampal expression of proteins associated with NMDA receptor functioning in schizophrenia. Poster session presented at the meeting of RCSI Research Day. Dublin, Ireland. 2002 Schubert, K. O., Schnell, O., Zhi, Q., Kirsch, M., Hoffmann, H. D., & Naumann, T. (2002). Endogenous ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF) differentially affect axotomized basal ferebrain neurons. Poster session presented at the meeting of 3rd Forum of European Neuroscience. Paris, France. 2002 Schubert, K. O., Schnell, O., Zhi, Q., Kirsch, M., Hofmann, H. D., & Naumann, T. (2002). Protective effects of endogenous ciliary neurotrophic factor on axotomized GABAergic forebrain neurons. Poster session presented at the meeting of 5th European Meeting on Glial Cell Function in Health and Disease. Rome, Italy. -
Theses
Year Citation 2014 Schubert, K. O. (2014). Effects of Schizophrenia, bipolar disorder, and haloperidol on the hippocampus: a proteomic approach. (PhD Thesis, Royal College of Surgeons in Ireland). -
Preprint
Year Citation 2024 Sharew, N., Clark, S., Schubert, O., & Amare, A. (2024). Pharmacogenomic scores in psychiatry: Systematic review of existing evidence.
DOI2024 Ahmed, M., Mulugeta, A., Okewole, N., Schubert, K. O., Clark, S., Iyegbe, C., & Amare, A. (2024). Pharmacogenomic Diversity in Psychiatry: Challenges and Opportunities in Africa.
DOI2023 Herrera-Rivero, M., Adli, M., Akiyama, K., Akula, N., Amare, A. T., Ardau, R., . . . Baune, B. T. (2023). Exploring the genetics of lithium response in bipolar disorders..
DOI2023 Herrera-Rivero, M., Gutiérrez-Fragoso, K., Thalamuthu, A., Amare, A., Adli, M., Akiyama, K., . . . Baune, B. (2023). Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder.
DOI2021 Kalman, J., Olde Loohuis, L., Vreeker, A., McQuillin, A., Stahl, E., Ruderfer, D., . . . Ophoff, R. (2021). Characterization of Age and Polarity at Onset in Bipolar Disorder.
DOI2017 Amare, A., Schubert, K. O., Cohen-Woods, S., & Baune, B. (2017). The genetic overlap between mood disorders and cardio-metabolic diseases: A systematic review of genome wide and candidate gene studies.
DOI
PhD funding: 2008-2014:
Clinician Scientist Fellowship, Molecular Medicine Ireland (MMI) Administered through RCSI, Ireland - EUR 180,000 (AUD 262,800)
Post-PhD funding:
2014:
RANZCP SA local branch research grant for undergraduate projects - AUD 2,500. Procter L, Stacey D, Schubert KO, Clark SR, Baune BT
2016:
Investigator Initiated Project (Industry Collaboration, Lundbeck): Trajecotories of Response to Abilify Maintena Study (TRAMS) – AUD 140.000 Baune BT, Clark SR, Schubert KO, Watson D.
RANZCP Research and Education Foundation Grant - AUD 10,000. Title: Developing blood biomarkers for long-term cognitive deficits in people with Major Depressive Disorder (MDD): Schubert KO
National Blood Authority Australia, National Blood Sector Research and Development Pilot Project Grant - AUD 139,000. Title: Preventive total dose of intravenous iron in pregnancy and beyond: Froessler B, Hodyl N, Stark M, Dekker G, Schubert KO
Society for Mental Health Research (SMHR) Early Career Researcher Project Grant - AUD 20,000. Title: Genomic and Proteomic validation of a gene expression module associated with poor response to lithium in Bipolar Affective Disorder: Schubert KO
Teaching
Undergraduate Programmes
MBBS Year 4 Clinical Psychiatry: introductury lectures (psychosis, psychopathology); exam-preparation tutorials; examiner for end-of-rotation examinations; preceptor for student placements at Lyell McEwin Hospital |
MBBS Year 5: examiner end-of-year examinations |
Faculty of Health Sciences Elective Course "Fundamentals of Biological Psychiatry": topic lectures - "clinical overview psychosis, mood disorder, anxiety disorders"; "biomarker research in psychiatry" |
Graduate Programmes
South Australian Psychiatric Training Committee (SAPTC): Seminars "First Episode Psychosis, Clinical Overview"; "Neurobiology of Depression and Medical Co-Morbidity" |
The Adelaide Pre-vocational Psychiatry Program (TAPPP): Seminar "Psychosis" |
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2024 Principal Supervisor Diagnosis and Treatment of Clozapine Associated Adverse Events and their Association with Inflammation Doctor of Philosophy Doctorate Full Time Mr Wei Ching Shawn Yong 2022 Principal Supervisor Investigating the substrate processes underlying the relationship between cognitive functioning and Anomalous Self-Experience, in adolescents with first-episode psychosis. Doctor of Philosophy Doctorate Full Time Mr James Christopher Martin 2022 Co-Supervisor Developing Genetic Testing Tools for Optimising Pharmacotherapy and Enabling a Precision Mental Health Care Doctor of Philosophy Doctorate Full Time Mr Nigussie Tadesse Sharew 2018 Principal Supervisor Investigation into the Relationship Between Mental Health, Genetics and Health Outcomes in Chronic and Terminal Lung Disease Doctor of Philosophy Doctorate Part Time Mrs Debra Gaye Sandford -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2015 - 2018 Co-Supervisor Genetic Predictors of Response to Pharmacotherapy in Patients with Mood Disorders: Steps on the Path to Personalised Psychiatry Doctor of Philosophy Doctorate Full Time Dr Azmeraw Tayelgn Amare
-
Board Memberships
Date Role Board name Institution name Country 2015 - ongoing Board Member Human Brain Protein Project (HBPP), Scientific Board Human Brain Protein Project (HBPP) - 2013 - ongoing Member Board of Examiners for Year 4/5 MBBS School of Medicine, The University of Adelaide - -
Committee Memberships
Date Role Committee Institution Country 2016 - ongoing Advisory Board Member Youth Mental Health Services Expert Advisory Group SA Health - 2015 - ongoing Member Early Career Psychiatrists Committee, 17th WPA World Congress of Psychiatry, Berlin, 2017 World Psychiatric Association - 2014 - 2015 Member 2014 SMHR Conference - Local Organising Committee Society for Mental Health Research Australia 2014 - 2014 Member 2014 SMHR Conference - Scientific Committee Society for Mental Health Research Australia 2014 - 2014 Co-Chair 2014 SMHR Conference - Social Committee Society for Mental Health Research Australia 2013 - ongoing Member Year 4/5 MBBS Course Committee The University of Adelaide, School of Medicine Australia -
Memberships
Date Role Membership Country 2014 - ongoing Member Australian Early Psychosis Research Network Australia 2013 - ongoing Member Society for Mental Health Research (SMHR) Australia 2013 - ongoing Member Fellowship of the Royal Australian and New Zealand College of Psychiatrists Australia 2013 - ongoing Member Royal College of Psychiatrists United Kingdom 2013 - ongoing Member Northern Adelaide Local Health Network - The University of Adelaide Liaison Committee Australia -
Editorial Boards
Date Role Editorial Board Name Institution Country 2016 - ongoing Board Member Irish Journal of Psychological Medicine - -
Connect With Me
External Profiles